Literature DB >> 24172842

A naturalistic, randomized, controlled trial combining cognitive remediation with cognitive-behavioural therapy after first-episode non-affective psychosis.

R J Drake1, C J Day2, R Picucci2, J Warburton2, W Larkin2, N Husain1, C Reeder3, T Wykes3, M Marshall1.   

Abstract

BACKGROUND: Cognitive remediation (CR) preceding cognitive-behavioural therapy for psychosis (CBTp) was trialled within routine clinical services, with the hypothesis that following first-episode non-affective psychosis CR would enhance CBTp efficacy by improving neuropsychological performance.
METHOD: A total of 61 patients with DSM-IV non-affective psychoses waiting for routine CBTp were randomized to computerized CR over 12 weeks, supported by a trained support worker, or time-matched social contact (SC). Primary outcome was the blind-rated Psychotic Symptoms Rating Scale (PSYRATS). Secondary outcomes included measures of CBTp progress, cognition, symptoms, insight and self-esteem: all at baseline, after CR (12 weeks) and after CBTp (42 weeks). PSYRATS and global neuropsychological efficacy were tested using mixed-effects models with a group × time interaction term. Measures of CBTp progress and some neuropsychological measures were modelled by regression.
RESULTS: There was no significant difference between the CR and SC groups in PSYRATS (group × time coefficient 0.3, 95% confidence interval -0.4 to 1.1, p = 0.39). However, after CR CBTp was shorter [median 7 sessions, interquartile range (IQR) 2-12 after CR; median 13, IQR 4-18 after SC; model p = 0.011] and linked to better insight (p = 0.02). Global cognition did not improve significantly more after CR (p = 0.20) but executive function did (Wisconsin Card Sort, p = 0.012).
CONCLUSIONS: CBTp courses preceded by CR were far shorter but achieved the same outcome as CBTp preceded by an active control, consistent with neuropsychological improvement enhancing CBTp. CR was delivered by staff with minimal training, offering the potential to reduce the costs of CBTp considerably.

Entities:  

Mesh:

Year:  2013        PMID: 24172842     DOI: 10.1017/S0033291713002559

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  13 in total

1.  Cognitive Training and Remediation in First-Episode Psychosis: A Literature Review.

Authors:  Kathleen Miley; Niloufar Hadidi; Merrie Kaas; Fang Yu
Journal:  J Am Psychiatr Nurses Assoc       Date:  2019-10-03       Impact factor: 2.385

2.  Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.

Authors:  Ariel Schvarcz; Carrie E Bearden
Journal:  Curr Behav Neurosci Rep       Date:  2015-01-18

3.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments.

Authors:  Paul H Lysaker; Michelle L Pattison; Bethany L Leonhardt; Scott Phelps; Jenifer L Vohs
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

4.  Durable Cognitive Gains and Symptom Improvement Are Observed in Individuals With Recent-Onset Schizophrenia 6 Months After a Randomized Trial of Auditory Training Completed Remotely.

Authors:  Rachel Loewy; Melissa Fisher; Sisi Ma; Cameron Carter; J Daniel Ragland; Tara A Niendam; Barbara Stuart; Danielle Schlosser; Felix Amirfathi; Seghel Yohannes; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

5.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

6.  Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial.

Authors:  Jessica A Wojtalik; Raquelle I Mesholam-Gately; Susan S Hogarty; Deborah P Greenwald; Maralee Y Litschge; Luis R Sandoval; Gautami Shashidhar; Synthia Guimond; Matcheri S Keshavan; Shaun M Eack
Journal:  Psychiatr Serv       Date:  2021-09-02       Impact factor: 4.157

7.  The Feasibility and Acceptability to Service Users of CIRCuiTS, a Computerized Cognitive Remediation Therapy Programme for Schizophrenia.

Authors:  Clare Reeder; Victoria Pile; Polly Crawford; Matteo Cella; Diana Rose; Til Wykes; Andrew Watson; Vyv Huddy; Felicity Callard
Journal:  Behav Cogn Psychother       Date:  2015-05-25

8.  A survey of eMedia-delivered interventions for schizophrenia used in randomized controlled trials.

Authors:  Farooq Naeem; Tariq Munshi; Shuo Xiang; Megan Yang; Farhad Shokraneh; Yumeen Syed; Muhammad Ayub; Clive E Adams; Saeed Farooq
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-27       Impact factor: 2.570

Review 9.  Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia.

Authors:  Philip D Harvey; Michael Sand
Journal:  Front Psychiatry       Date:  2017-09-25       Impact factor: 4.157

10.  A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial.

Authors:  C Reeder; V Huddy; M Cella; R Taylor; K Greenwood; S Landau; T Wykes
Journal:  Psychol Med       Date:  2017-09-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.